Loading companies…
Loading companies…
Canada · Biotech · AI
Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed+ | Undisclosed | Anges Québec — Role not disclosedCQDM — Role not disclosedMerck Global Health Innovation Fund — Role not disclosedReal Ventures — Role not disclosedSkeleton Key — Role not disclosed |